The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling

AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Park, Kyungil, Kim, Young‐Dae, Kim, Ki‐Sik, Lee, Su‐Hoon, Park, Tae‐Ho, Lee, Sang‐Gon, Kim, Byung‐Soo, Hur, Seung‐Ho, Yang, Tae‐Hyun, Oh, Joo‐Hyun, Hong, Taek‐Jong, Park, Jong‐Sun, Hwang, Jin‐Yong, Jeong, Byungcheon, Bae, Woo‐Hyung
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5880661/
https://ncbi.nlm.nih.gov/pubmed/29341471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12249
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi